![]() MacroGenics MacroGenics is a biotechnology company developing immunotherapeutics to prevent autoimmune disorders, cancer and infectious diseases. | ![]() Cipla Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products. | Biogen Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases. | |
Founding Date | Founding Date 2000 | Founding Date 1935 | Founding Date 1978 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Rockville, US HQ Brisbane, US Rockville, US | Locations Mumbai, IN HQ Melbourne, AU Antwerpen, BE São Paulo, BR São Paulo, BR Unterhaching, DE Nairobi, KE see more | Locations Cambridge, US HQ Vicente López, AR Macquarie Park, AU Wien, AT Machelen, BE São Paul, BR Toronto, CA see more |
Employees | Employees 3845% increase | Employees 27,764 | Employees 7,605 |
Valuation ($) | Valuation ($) 209.5 m | Valuation ($) N/A | Valuation ($) 26.7 b |
Financial | |||
Revenue (est.) | Revenue (est.) $149.5m (FY, 2025) | Revenue (est.) ₹277.1b (FY, 2026) | Revenue (est.) $9.9b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods ₹97.2b (FY, 2026) | Cost of goods $2.4b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit ₹184.4b (FY, 2026) | Gross profit $7.5b (FY, 2025) |
Net income | Net income ($74.6m) (FY, 2025) | Net income ₹38.7b (FY, 2026) | Net income $1.3b (FY, 2025) |

Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.
View companyBiogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases.
View company